Haemophilus influenzae Type b Vaccine: Reconstitution of Lyophilised PRP-T Vaccine with a Pertussis-containing Paediatric Combination Vaccine, or a Change in the Primary Series Immunisation Schedule, May Modify the Serum Anti-PRP Antibody Responses

References

• Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000;13(2):302–17
   PubMed Web of Science ®Google Scholar
• Eskola J, Ward J, Dagan R, Goldblatt D, Zepp F, Siegrist CA. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria–tetanus–pertussis containing acellular pertussis. Lancet 1999;354(9195):2063–8
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services, Food and Drug Administration Center for Biologics Evaluation and Research. Guidance for industry for the evaluation of combination vaccines for preventable diseases: production, testing and clinical studies (1997)
   Google Scholar
• European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products. Note for guidance on clinical evaluation of new vaccines. CPMP/EWP/463/97, May (1999)
   Google Scholar
• Schneerson R, Barrera O, Sutton A, Robbins JB. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Expl Med 1980;152(2):361–76
   PubMed Web of Science ®Google Scholar
• Ward JI, Greenberg DP, Anderson PW, Burkart KS, Christenson PD, Gordon LK, Kayhty H, Kuo JS, Vella P. Variable quantitation of Haemophilus influenzae type b anti-capsular antibody by radioantigen binding assay. J Clin Microbiol 1988;26(1):72–8
   PubMed Web of Science ®Google Scholar
• Madore DV. Characterization of immune response as an indicator of Haemophilus influenzae type b vaccine efficacy. Pediatr Infect Dis J 1998;17(Suppl 9):S207–S210
   PubMed Web of Science ®Google Scholar
• Insel RA. Potential alterations in immunogenicity by combining or simultaneously administering vaccine components. Ann NY Acad Sci 1995;754:35–47
   PubMed Web of Science ®Google Scholar
• Finn A, Blondeau C, Bell F. Haemophilus influenzae type B (Hib) antibody responses in children given diphtheria–tetanus–acellular pertussis-Hib combination vaccines (letter). J Infect Dis 2000;181(6):2117–8
   PubMed Web of Science ®Google Scholar
• Goldblatt D, Richmond P, Millard E, Miller E. Haemophilus influenzae type B (Hib) antibody responses in children given diphtheria–tetanus-acellular pertussis-Hib combination vaccines (reply). J Infect Dis 2000;181(6):2118
   PubMed Web of Science ®Google Scholar
• Gupta RK. Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev 1998;32(3):155–72
   PubMed Web of Science ®Google Scholar
• Dagan R, Eskola J, Leclerc C, Leroy O. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun 1998;66(5):2093–8
   PubMed Web of Science ®Google Scholar
• Hem SL, White JL. Characterization of aluminium hydroxide for use as an adjuvant in parenteral vaccines. J Parenter Sci Technol 1984;38(1):2–11
   PubMedGoogle Scholar
• Shirodkar S, Hutchinson RL, Perry DL, White JL, Hem SL. Aluminum compounds used as adjuvants in vaccines. Pharm Res 1990;7(12):1282–8
   PubMed Web of Science ®Google Scholar
• Shams H, Heron I. Mutual interactions between DTaP-IPV and Haemophilus influenzae type b (Hib)-conjugated vaccines in laboratory animal models. Biologicals 1999;27(3):227–40
   PubMed Web of Science ®Google Scholar
• Ferreccio C, Clemens J, Avendano A, Horwitz I, Flores C, Avila L, Cayazzo M, Fritzell B, Cadoz M, Levine M. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide–tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria–tetanus toxoids–pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1991;10(10):764–71
   PubMed Web of Science ®Google Scholar
• Clemens JD, Ferreccio C, Levine MM, Horwitz I, Rao MR, Edwards KM, Fritzell B. Impact of Haemophilus influenzae type b polysaccharide–tetanus protein conjugate vaccine on responses to concurrently administered diphtheria–tetanus–pertussis vaccine. J Am Med Assoc 1992;267(5):673–8
   Web of Science ®Google Scholar
• Avendano A, Ferreccio C, Lagos R, Horwitz I, Cayazzo M, Fritzell B, Meschievitz C, Levine M. Haemophilus influenzae type b polysaccharide–tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria–tetanus–pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1993;12(8):638–43
   PubMed Web of Science ®Google Scholar
• Hoppenbrouwers K, Lagos R, Swennen B, Ethevenaux C, Knops J, Levine MM, Desmyter J. Safety and immunogenicity of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria–tetanus–pertussis (DTP) combination vaccine administered in a dual-chamber syringe to infants in Belgium and Chile. Vaccine 1998;16(9–10):921–7
   PubMed Web of Science ®Google Scholar
• Lagos R, Kotloff K, Hoffenbach A, San Martin O, Abrego P, Ureta AM, Pines E, Blondeau C, Bailleux F, Levine MM. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants. Pediatr Infect Dis J 1998;17(4):294–304
   PubMed Web of Science ®Google Scholar
• Levine OS, Granoff DM, Lagos R, Fritzell B, Levine MM. Factors associated with superior antibody responses to a single dose of Haemophilus influenzae type b–tetanus toxoid conjugate vaccine administered to Chilean infants at 2 months of age. Vaccine 1997;15(3):325–8
   PubMed Web of Science ®Google Scholar
• Hoppenbrouwers K, Kanra G, Roelants M, Ceyhan M, Vandermeulen C, Yurdakok K, Silier T, Dupuy M, Pehlivan T, Ozmert E, et al. Priming effect, immunogenicity and safety of an Haemophilus influenzae type b–tetanus toxoid conjugate (PRP-T) and diphtheria–tetanus–acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey. Vaccine 1999;17(7–8):875–86
   PubMed Web of Science ®Google Scholar
• Kanra G, Yurdakok K, Ceyhan M, Ozmert E, Turkay F, Pehlivan T. Immunogenicity and safety of Haemophilus influenzae type b capsular polysaccharide tetanus conjugate vaccine (PRP-T) presented in a dual-chamber syringe with DTP. Acta Paediatr Jpn 1997;39(6):676–80
   PubMedGoogle Scholar
• Kanra G, Silier T, Yurdakok K, Yavuz T, Baskan S, Ulukol B, Ceyhan M, Ozmert E, Turkay F, Pehlivan T. Immunogenicity study of a combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis vaccine used to reconstitute a freeze-dried Haemophilus influenzae type b vaccine (DTaP-IPV//PRPT) administered simultaneously with a hepatitis B vaccine at two, three and four months of life. Vaccine 2000;18 (9–10):947–54
   Web of Science ®Google Scholar
• al-Mazrou YY, Khalil MK, Al-Howasi MN, Al-Jeffri MH, Elgizouli SE. Immunogenicity study for tetra and penta component vaccines in infants. Saudi Med J 1999;20(10):770–4
   Web of Science ®Google Scholar
• Capeding MR, Nohynek H, Pascual LG, Kayhty H, Sombrero LT, Eskola J, Ruutu P. The immunogenicity of three Haemophilus influenzae type B conjugate vaccines after a primary vaccination series in Philippine infants. Am J Trop Med Hyg 1996;55(5):516–20
   PubMed Web of Science ®Google Scholar
• Capeding MR, Nohynek H, Kayhty H, Pascual LG, Sunico ES, Tamundong AA, Ruutu P. Antibody responses of three Haemophilus influenzae type b conjugate vaccines after one, two and three doses in Filipino children. Vaccine 1998;16 (9–10):1004–8
   PubMed Web of Science ®Google Scholar
• Fernandez J, Balter S, Feris J, et al. Randomized trial of the immunogenicity of fractional-dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine. Am J Trop Med Hyg 2000;62:485–90
   PubMed Web of Science ®Google Scholar
• Lee CY, Thipphawong J, Huang LM, Lee PI, Chiu HH, Lin W, Debois H, Harrison D, Xie F, Barreto L. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b–tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants. Pediatr. 1999;103(1):25–30
   PubMed Web of Science ®Google Scholar
• Heath PT, Booy R, Azzopardi HJ, Slack MP, Bowen-Morris J, Griffiths H, Ramsay ME, Deeks JJ, Moxon ER. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. J Am Med Assoc 2000;284(18):2334–40
   PubMed Web of Science ®Google Scholar
• Parke JC Jr, Schneerson R, Reimer C, Black C, Welfare S, Bryla D, Levi L, Pavliakova D, Cramton T, Schulz D. Clinical and immunologic responses to Haemophilus influenzae type b–tetanus toxoid conjugate vaccine in infants injected at 3, 5, 7, and 18 months of age. J Pediatr 1991;118(2):184–90
   PubMed Web of Science ®Google Scholar
• Mulholland EK, Hoestermann A, Ward JI, Maine N, Ethevenaux C, Greenwood BM. The use of Haemophilus influenzae type b–tetanus toxoid conjugate vaccine mixed with diphtheria–tetanus–pertussis vaccine in Gambian infants. Vaccine 1996;14(9):905–9
   PubMed Web of Science ®Google Scholar
• Mulholland EK, Byass P, Campbell H, Fritzell B, Greenwood AM, Todd J, Greenwood BM. The immunogenicity and safety of Haemophilus influenzae type b–tetanus toxoid conjugate vaccine in Gambian infants. Ann Trop Paediatr 1994;14(3):183–8
   PubMed Web of Science ®Google Scholar
• Kumar A, Dutta AK, Saili A, Nangia S, Dutta R. Immunogenicity and tolerance of H. influenzae type b, tetanus toxoid conjugate vaccine given concurrently or in combination. Ind J Pediatr 1997;64(6):839–47
   PubMedGoogle Scholar
• Begg NT, Miller E, Fairley CK, Chapel HM, Griffiths H, Waight PA, Ashworth LAE. Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type B conjugate vaccines given for primary immunisation by separate or mixed injection. Vaccine 1995;13(16):1547–50
   PubMed Web of Science ®Google Scholar
• Booy R, Taylor SA, Dobson SR, Isaacs D, Sleight G, Aitken S, Griffiths H, Chapel H, Mayon-White RT, Macfarlane JA. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule. Arch Dis Child 1992;67(4):475–8
   PubMed Web of Science ®Google Scholar
• Araujo OO, Forleo-Neto E, Vespa GN, Puccini RF, Weckx LW, Carvalho ES, Farhat CK. Associated or combined vaccination of Brazilian infants with a conjugate Haemophilus influenzae type b (Hib) vaccine, a diphtheria–tetanus–whole-cell pertussis vaccine and IPV or OPV elicits protective levels of antibodies against Hib. Vaccine 2000;19(2–3):367–75
   PubMed Web of Science ®Google Scholar
• Scheifele D, Barreto L, Meekison W, Guasparini R, Friesen B. Can Haemophilus influenzae type b–tetanus toxoid conjugate vaccine be combined with diphtheria toxoid–pertussis vaccine–tetanus toxoid? Can Med Assoc J 1993;149(8):1105–12
   Web of Science ®Google Scholar
• Scheifele DW, Meekison W, Guasparini R, Roberts A, Barreto L, Thipphawong J, Wiltsey S. Evaluation of booster doses of Haemophilus influenzae type b–tetanus toxoid conjugate vaccine in 18-month old children. Vaccine 1995;13(1):104–8
   PubMed Web of Science ®Google Scholar
• Miller MA, Meschievitz CK, Ballanco GA, Daum RS. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. Pediatr 1995;95(4):522–7
   PubMed Web of Science ®Google Scholar
• Decker MD, Edwards KM, Bradley R, Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines (see comments). J Pediatr 1992;120(2 Pt 1):184–9
   PubMedGoogle Scholar
• Greenberg DP, Lieberman JM, Marcy SM, Wong VK, Partridge S, Chang SJ, Chiu CY, Ward JI. Enhanced antibody responses in infants given sequences of heterogeneous Haemophilus influenzae type b conjugate vaccine. J Pediatr 1995;126(2):206–11
   PubMed Web of Science ®Google Scholar
• Bewley KM, Schwab JG, Ballanco GA, Daum RS. Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimen. Pediatr 1996;98(5):898–904
   PubMed Web of Science ®Google Scholar
• Kaplan SL, Lauer BA, Ward MA, Wiedermann BL, Boyer KM, Dukes CM, Schaffer DM, Paisley J, Mendelson R, Pedreira F, et al. Immunogenicity and safety of Haemophilus influenzae type b–tetanus protein conjugate vaccine alone or mixed with diphtheria–tetanus–pertussis vaccine in infants. J Pediatr 1994;124(2):323–7
   PubMed Web of Science ®Google Scholar
• Bulkow LR, Wainwright RB, Letson GW, Chang SJ, Ward JI. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska native infants. Pediatr Infect Dis J 1993;12(6):484–92
   PubMed Web of Science ®Google Scholar
• Granoff DM, Anderson EL, Osterholm MT, Holmes SJ, McHugh JE, Belshe RB, Medley F, Murphy TV. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J Pediatr 1992;121(2):187–94
   PubMed Web of Science ®Google Scholar
• Granoff DM, Holmes SJ, Osterholm MT, McHugh JE, Lucas AH, Anderson EL, Belshe RB, Jacobs JL, Medley F, Murphy TV. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J Infect Dis 1993;168(3):663–71
   PubMed Web of Science ®Google Scholar
• Greenberg DP, Vadheim CM, Marcy SM, Ward JI. Evaluation of the safety, immunogenicity, and efficacy of Haemophilus b (Hib) PRP-T conjugate vaccine in a prospective, randomized and placebo-controlled trial in young infants (Abstract). The 31st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (1991)
   Google Scholar
• Boucher J, Ethevenaux C, Guyot C, Leroux MC, Fritzell B, Saliou P, Reinert P. Essai de prévention des infections graves à Haemophilus influenzae type b et essai de tolérance, après vaccination PRP-T, dans le département du Val-de-Marne. Arch Pediatr 1996;3(8):775–81
   PubMedGoogle Scholar
• Langue J, Ethevenaux C, Champsaur A, Fritzell B, Begue P, Saliou P. Safety and immunogenicity of Haemophilus influenzae type b–tetanus toxoid conjugate, presented in a dual-chamber syringe with diphtheria–tetanus–pertussis and inactivated poliomyelitis combination vaccine. Eur J Pediatr 1999;158:717–22
   PubMed Web of Science ®Google Scholar
• Gold R, Scheifele D, Barreto L, Wiltsey S, Bjornson G, Meekison W, Guasparini R, Medd L. Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. Pediatr Infect Dis J 1994;13(5):348–55
   PubMed Web of Science ®Google Scholar
• Langue J, Fritzell B, Preziozi MP, Houmeau P. Evaluation de la vaccination des enfants de 3 mois avec le polyoside capsulaire d’Haemophilus influenzae type B (Hib) conjugé à la toxine tétanique (PRP-T). Pediatrie 1991;46(12):821–4
   PubMedGoogle Scholar
• Schmitt HJ, Zepp F, Muschenborn S, Sumenicht G, Schuind A, Beutel K, Knuf M, Bock HL, Bogaerts H, Clemens R. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria–tetanus–toxoid and acellular pertussis vaccine for primary and for booster immunizations. Eur J Pediatr 1998;157(3):208–14
   PubMed Web of Science ®Google Scholar
• Liese JG, Harzer E, Hosbach P, Froeschle J, Meschievitz C. Hib antibody response of a combined DTaP-PRP-T conjugate vaccine compared to separate injections in infants (Abstract G105). The 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (1996)
   Google Scholar
• Pichichero ME, Latiolais T, Bernstein DI, Hosbach P, Christian E, Vidor E, Meschievitz C, Daum RS. Vaccine antigen interactions after a combination diphtheria–tetanus toxoid–acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b–tetanus toxoid vaccine in two, four- and six-month-old infants. Pediatr Infect Dis J 1997;16(9):863–70
   PubMed Web of Science ®Google Scholar
• Rennels MB, Englund JA, Bernstein DI, Losonsky GA, Anderson EL, Pichichero ME, Munoz FM, Wolff MC. Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria–tetanus–acellular pertussis/ Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination. Pediatr Infect Dis J 2000;19(5):417–23
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Passador S. Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine. Clin Infect Dis 1997;25(6):1378–84
   PubMed Web of Science ®Google Scholar
• Langue J, David T, Roussel F, Pines E, Hoffenbach A, Association Française de Pédiatrie Ambulatoire: Safety and immunogenicity of DTaP-IPV and Act-HIB vaccines administered either combined or separately to infants at 2, 3, and 4 months of age (Abstract 79). The 15th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID) (1997)
   Google Scholar
• Mills E, Gold R, Thipphawong J, Barreto L, Guasparini R, Meekison W, Cunning L, Russell M, Harrison D, Boyd M et al. Safety and immunogenicity of a combined five-component pertussis – diphtheria – tetanus – inactivated poliomyelitis–Haemophilus B conjugate vaccine administered to infants at two, four and six months of age. Vaccine 1998;16(6):576–85
   PubMed Web of Science ®Google Scholar
• Blatter M, Resinger K, Bottenfield G, Edwards K, McCarthy K, Nauert B, Wowe B, Grek V, Kaufhold A. Evaluation of the reactogenicity and immunogenicity of a new combined DTacP-HBV-IPV vaccine coadministered with Hib vaccine at 2, 4, and 6 months of age. Abstracts of the Infectious Diseases Society of America (IDSA), 37th Annual Meeting (1999)
   Google Scholar
• Usonis V, Bakasenas V. Does concomitant injection of a combined diphtheria–tetanus–acellular pertussis–hepatitis B virus-inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines? Eur J Pediatr 1999;158(5):398–402
   PubMed Web of Science ®Google Scholar
• Goldblatt D, Fairley CK, Cartwright K, Miller E. Interchangeability of conjugated Haemophilus influenzae type b vaccines during primary immunisation of infants. BMJ 1996;312(7034):817–8
   PubMed Web of Science ®Google Scholar
• Goldblatt D, Miller E, McCloskey N, Cartwright K. Immunological response to conjugate vaccines in infants: follow up study. BMJ 1998;316(7144):1570–1
   PubMed Web of Science ®Google Scholar
• Hoppenbrouwers K, Roelants M, Ethevenaux C, Vandermeulen C, Knops J, Desmyter J. The effect of reconstitution of an Haemophilus influenzae type b–tetanus toxoid conjugate (PRP-T) vaccine on the immune responses to a diphtheria–tetanus–whole cell pertussis (DTwP) vaccine: A five-year follow-up. Vaccine 1999;17(20/21):2588–98
   PubMed Web of Science ®Google Scholar
• Watemberg N, Dagan R, Arbelli Y, Belmaker I, Morag A, Hessel L, Fritzell B, Bajard A, Peyron L. Safety and immunogenicity of Haemophilus type b–tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria–tetanus–pertussis vaccine in young infants. Pediatr Infect Dis J 1991;10(10):758–63
   PubMed Web of Science ®Google Scholar
• Barra A, Dagan R, Preud’homme JL, Bajart A, Danve B, Fritzell B. Characterization of the serum antibody response induced by Haemophilus influenzae type b tetanus protein-conjugate vaccine in infants receiving a DTP-combined vaccine from 2 months of age. Vaccine 1993;11(10):1003–6
   PubMed Web of Science ®Google Scholar
• Amir J, Melamed R, Bader J, Ethevenaux C, Fritzell B, Cartier JR, Arminjon F, Dagan R. Immunogenicity and safety of a liquid combination of DTP-PRP-T (corrected) vs lyophilized PRP-T reconstituted with DTP (published erratum appears in Vaccine 1997:Nov;15(16):1813). Vaccine 1997;15(2):149–54
   PubMed Web of Science ®Google Scholar
• Campagne G, Garba A, Schuchat A, Boulanger D, Plikaytis BD, Ousseini M, Chippaux JP. Response to conjugate Haemophilus influenzae B vaccine among infants in Niamey, Niger. Am J Trop Med Hyg 1998;59(5):837–42
   PubMed Web of Science ®Google Scholar
• Kurikka S, Kayhty H, Saarinen L, Ronnberg P, Eskola J, Makela PH. Comparison of five different vaccination schedules with Haemophilus influenzae type b–tetanus toxoid conjugate vaccine. J Pediatr 1996;128(4):524–30
   PubMed Web of Science ®Google Scholar
• Bell F, Martin A, Blondeau C, Thornton C, Chaplais J, Finn A. Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisation. Arch Dis Child 1996;75(4):298–303
   PubMed Web of Science ®Google Scholar
• Dagan R, Igbaria K, Piglansky L, Melamed R, Willems P, Grossi A, Kaufhold A. Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b–tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine. Pediatr Infect Dis J 1997;16(12):1113–21
   PubMed Web of Science ®Google Scholar
• Dagan R, Botujansky C, Watemberg N, Arbelli Y, Belmaker I, Ethevenaux C, Fritzell B. Safety and immunogenicity in young infants of Haemophilus b–tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria–tetanus–pertussis-enhanced inactivated poliovirus vaccine. Pediatr Infect Dis J. 1994;13(5):356–62
   PubMed Web of Science ®Google Scholar
• Vesikari T, Joensuu J, Baer M, Kayhty H, Olander RM, Sormunen H, Miettinen A, Ward RL, Guillot T. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria–pertussis–tetanus–Haemophilus influenzae b-inactivated polio and hepatitis B vaccines. Acta Paediatr. 1999;88(5):513–20
   PubMed Web of Science ®Google Scholar
• Bell F, Heath P, Shackley F, MacLennan J, Shearstone N, Diggle L, Griffiths H, Moxon ER, Finn A. Effect of combination with an acellular pertussis, diphtheria, tetanus vaccine on antibody response to Hib vaccine (PRP-T). Vaccine 1998;16(6):637–42
   PubMed Web of Science ®Google Scholar
• Bell F, Health P, Shackley F, MacLennan J, Herbert M, Shearstone N, Diggle L, Moxon ER, Finn A. Poor response to Hib (PRP-T) vaccine when combined with an acellular pertussis/diphtheria/tetanus vaccine for primary immunization of infants. Biologicals 1999;27(2):113
   PubMed Web of Science ®Google Scholar
• Daum RS, Zenko CE, Given GZ, Ballanco GA, Parikh H, Vidor E, Liu X. Absence of a significant interaction between a Haemophilus influenzae conjugate vaccine combined with a diphtheria toxoid, tetanus toxoid and acellular pertussis vaccine in the same syringe and inactivated polio vaccine. Pediatr Infect Dis J. 2000: 19(8);710–7
   PubMed Web of Science ®Google Scholar
• Mallet E, Hoffenbach A, Salomon H, Blondeau C, Fritzell B. Primary immunization with combined acellular DTaP-IPV-Act-HIB vaccine given at 2–3–4 or 2–4–6 months of age (Abstract19). The 14th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID) (1996)
   Google Scholar
• Carlsson RM, Claesson BA, Selstam U, Fagerlund E, Granstrom M, Blondeau C, Hoffenbach A. Safety and immunogenicity of a combined diphtheria–tetanus–acellular pertussis-inactivated polio vaccine–Haemophilus influenzae type b vaccine administered at 2–4–6–13 or 3–5–12 months of age. Pediatr Infect Dis J 1998:17(11);1026–33
   PubMed Web of Science ®Google Scholar
• Mallet E, Fabre P, Pines E, Salomon H, Staub T, Schödel F, Mendelman P, Hessel L, Chryssomalis G, Vidor E, HoffenbachA. The Hexavalent Vaccine Trial Study Group: Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants. Paed Infect Dis J 2000:1912;1119–27
   Google Scholar
• Taranger J, Trollfors B, Knutsson N, Sundh V, Lagergard T, Ostergaard E. Vaccination of infants with a four-dose and a three-dose vaccination schedule. Vaccine 2000:18(9–10); 884–91
   Web of Science ®Google Scholar